Spark Therapeutics - PharmaKB

Company Reports

Company Reports

Disease Reports

Disease Reports

Company ReportsSpark Therapeutics

Spark Therapeutics(ONCE)

Spark Therapeutics, Inc. is a developer of gene therapy treatments, which treat debilitating genetic diseases. It is a subsidiary of Hoffmann-La Roche.

Download report

Favorite

Financial

Marketed Drugs

Clinical Trials

Financial

Stock price

*Currency in USD

Company Revenue

Quarterly

Quarterly

Annual

Annual

Projections

*Quarterly sales USD (in millions)

Plot placeholder

Mock data
Subscribe for the real data

Revenue by Drug

Marketed Drugs

Therapeutic Areas:

All

Classification:

All

Include Generics:

Trade Name	Drug Name	Approved	Patent Expires	Indication
Luxturna	Voretigene neparvovec	2017-12-19		Retinitis pigmentosa , Leber congenital amaurosis

Clinical Trials

Therapeutic Areas:

All

Classification:

All

Approval:

All

Status:

All

Phases:

All

Drug Name

Phase 1

Phase 2

Phase 3

Phase 4

Indication

Voretigene neparvovec

retinal dystrophies

prostatic neoplasms

,

castration-resistant prostatic neoplasms

Globulin, immune

myelodysplastic syndromes

,

graft vs host disease

,

bcr-abl positive chronic myelogenous leukemia

,

myeloid leukemia

,

,

myeloid leukemia acute

,

hematologic neoplasms

,

discoid lupus erythematosus

,

lupus nephritis

,

central nervous system lupus vasculitis

,

,

systemic lupus erythematosus

,

central nervous system vasculitis

,

cutaneous lupus erythematosus

,

,

neoplasm metastasis

,

gastrointestinal neoplasms

,

biliary tract neoplasms

,

colorectal neoplasms

,

,

,

b-cell lymphoma

,

,

pancreatic neoplasms

,

mantle-cell lymphoma

,

,

,

,

urinary bladder neoplasms

,

liver cirrhosis

,

,

chronic hepatitis b

,

,

hepatocellular carcinoma

,

squamous cell carcinoma of head and neck

,

liver neoplasms

,

urologic neoplasms

,

transitional cell carcinoma

,

,

invasive hydatidiform mole

,

brain neoplasms

,

large b-cell lymphoma diffuse

,

b-cell leukemia

,

rectal neoplasms

,

castration-resistant prostatic neoplasms

,

endometrial neoplasms

,

esophageal neoplasms

,

uterine cervical neoplasms

,

ovarian epithelial carcinoma

,

colonic neoplasms

,

multiple myeloma

,

precursor cell lymphoblastic leukemia-lymphoma

,

plasma cell neoplasms

,

,

prolymphocytic leukemia

,

thyroid diseases

,

chronic renal insufficiency

,

kidney diseases

,

chronic hepatitis

,

prostatic neoplasms

,

renal cell carcinoma

,

,

small cell lung carcinoma

,

liver transplantation

,

,

non-alcoholic fatty liver disease

,

,

sclerosing cholangitis

,

,

precursor t-cell lymphoblastic leukemia-lymphoma

,

thrombocytopenic purpura idiopathic

,

thrombocytopenic purpura

,

,

large-cell lymphoma anaplastic

,

gastrointestinal diseases

,

,

relapsing-remitting multiple sclerosis

,

papillary thyroid cancer

,

medullary carcinoma

,

,

hairy cell leukemia

,

reactive arthritis

,

prolymphocytic leukemia b-cell

,

ovarian neoplasms

,

male breast neoplasms

,

,

thyroid neoplasms

,

anaplastic thyroid carcinoma

,

autoimmune diseases

,

respiratory syncytial virus infections

,

,

mouth neoplasms

,

oropharyngeal neoplasms

,

laryngeal neoplasms

,

hypopharyngeal neoplasms

,

,

b-cell chronic lymphocytic leukemia

,

,

breast neoplasms

,

non-hodgkin lymphoma

,

,

lymphoid leukemia

,

non-small-cell lung carcinoma

,

follicular lymphoma

,

triple negative breast neoplasms

,

waldenstrom macroglobulinemia

,

b-cell lymphoma marginal zone

,

stomach neoplasms

,

rheumatoid arthritis

,

psoriatic arthritis

,

,

,

acquired immunodeficiency syndrome

,

chronic hepatitis c

,

© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use